KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme Group (CME) EBIT Margin: 2009-2025

Historic EBIT Margin for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to 63.25%.

  • Cme Group's EBIT Margin fell 139.00% to 63.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.98%, marking a year-over-year increase of 132.00%. This contributed to the annual value of 64.13% for FY2024, which is 255.00% up from last year.
  • Cme Group's EBIT Margin amounted to 63.25% in Q3 2025, which was down 5.23% from 66.74% recorded in Q2 2025.
  • Over the past 5 years, Cme Group's EBIT Margin peaked at 67.47% during Q1 2025, and registered a low of 55.06% during Q4 2021.
  • In the last 3 years, Cme Group's EBIT Margin had a median value of 63.38% in 2023 and averaged 63.66%.
  • Over the last 5 years, Cme Group's EBIT Margin had its largest YoY gain of 818bps in 2021, and its largest YoY loss of 521bps in 2021.
  • Over the past 5 years, Cme Group's EBIT Margin (Quarterly) stood at 55.06% in 2021, then increased by 27bps to 55.33% in 2022, then soared by 464bps to 59.97% in 2023, then soared by 212bps to 62.09% in 2024, then plummeted by 139bps to 63.25% in 2025.
  • Its EBIT Margin was 63.25% in Q3 2025, compared to 66.74% in Q2 2025 and 67.47% in Q1 2025.